SF17 launched in 2018 at a Y Combinator S18 Demo Day, and is now headquartered in San Francisco, California. The founding team for SF17 Therapeutics previously founded Simpatica Medicine. SF17 is one of the startup companies that joined the CITRIS Foundry at UC Berkeley in 2018.
Through patient monitoring, the SF17 platform allows paediatricians to match patients with patient-specific treatment regimens or regimen changes. The platform is also being used to identify targets for new drug compound development.
SF17 Therapeutics was founded.
Co-Founder and CTO
All 59 startups that launched today at Y Combinator's S18 Demo Day 2
Lucas Matney, Connie Loizos, Jonathan Shieber, Anna Escher, Anthony Ha
Six new startups join the CITRIS Foundry portfolio of science-driven companies
Documentaries, videos and podcasts
- Simpatica MedicineSimpatica Medicine is an AI company founded in 2015 and based in San Francisco, California, that built a Cloud AI for the purpose of interpreting the ability of individual patients to respond to therapeutics in order to guide precision treatments for cancer immune therapies and auto-immune disease.